Your browser doesn't support javascript.
loading
Female and preserved platelet count subgroups of myelodysplastic syndrome patients benefit from standard-dose azacitidine.
Ogawa, Shinichi; Sakamoto, Tatsuhiro; Matsuoka, Ryota; Ishitsuka, Kantaro; Ogino, Yasuko; Sootome, Ayano; Makishima, Kenichi; Yoshida, Chikashi; Ito, Yufu; Shimizu, Seiichi; Suyama, Takuya; Shinagawa, Atsushi; Ito, Takayoshi; Obara, Naoshi; Kusakabe, Manabu; Sakata-Yanagimoto, Mamiko; Miyazaki, Yasushi; Nannya, Yasuhito; Chiba, Shigeru.
Afiliación
  • Ogawa S; Division of Hematology, JA Toride General Medical Center, Toride, Ibaraki, Japan.
  • Sakamoto T; Department of Hematology, Faculty of Medicine, University of Tsukuba, Tsukuba, Ibaraki, Japan.
  • Matsuoka R; Department of Pathology, Faculty of Medicine, University of Tsukuba, Tsukuba, Ibaraki, Japan.
  • Ishitsuka K; Graduate School of Comprehensive Human Sciences, University of Tsukuba, Tsukuba, Ibaraki, Japan.
  • Ogino Y; Division of Hematology, JA Toride General Medical Center, Toride, Ibaraki, Japan.
  • Sootome A; Department of Hematology, Faculty of Medicine, University of Tsukuba, Tsukuba, Ibaraki, Japan.
  • Makishima K; Graduate School of Comprehensive Human Sciences, University of Tsukuba, Tsukuba, Ibaraki, Japan.
  • Yoshida C; Division of Hematology, National Hospital Organization Mito Medical Center, Mito, Ibaraki, Japan.
  • Ito Y; Division of Hematology, Tsuchiura Kyoudou General Hospital, Tsuchiura, Ibaraki, Japan.
  • Shimizu S; Division of Hematology, Tsuchiura Kyoudou General Hospital, Tsuchiura, Ibaraki, Japan.
  • Suyama T; Division of Hematology, Hitachi General Hospital, Hitachi, Ibaraki, Japan.
  • Shinagawa A; Division of Hematology, Hitachi General Hospital, Hitachi, Ibaraki, Japan.
  • Ito T; Division of Hematology, JA Toride General Medical Center, Toride, Ibaraki, Japan.
  • Obara N; Department of Hematology, Faculty of Medicine, University of Tsukuba, Tsukuba, Ibaraki, Japan.
  • Kusakabe M; Department of Hematology, Faculty of Medicine, University of Tsukuba, Tsukuba, Ibaraki, Japan.
  • Sakata-Yanagimoto M; Department of Hematology, Faculty of Medicine, University of Tsukuba, Tsukuba, Ibaraki, Japan.
  • Miyazaki Y; Department of Hematology, Atomic Bomb Disease Institute, Nagasaki University, Nagasaki, Japan.
  • Nannya Y; Department of Hematology, Institute of Medical Science, University of Tokyo, Tokyo, Japan.
  • Chiba S; Department of Hematology, Faculty of Medicine, University of Tsukuba, Tsukuba, Ibaraki, Japan.
Cancer Rep (Hoboken) ; 7(1): e1938, 2024 01.
Article en En | MEDLINE | ID: mdl-38014499
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Azacitidina / Síndromes Mielodisplásicos Límite: Female / Humans / Male Idioma: En Revista: Cancer Rep (Hoboken) Año: 2024 Tipo del documento: Article País de afiliación: Japón
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Azacitidina / Síndromes Mielodisplásicos Límite: Female / Humans / Male Idioma: En Revista: Cancer Rep (Hoboken) Año: 2024 Tipo del documento: Article País de afiliación: Japón